Gabriella Cirmena
- Cancer Research top 10%
- Cancer Genomics and Diagnostics 9
- Hematology top 10%
- Chronic Myeloid Leukemia Treatments 8
- Genetics top 10%
- Chronic Lymphocytic Leukemia Research 6
-
- HER2/EGFR in Cancer Research 5
- PARP inhibition in cancer therapy 4
-
- Genetic factors in colorectal cancer 6
-
- Alzheimer's disease research and treatments 4
-
- Eosinophilic Disorders and Syndromes 4
- Co-authors
- Alberto BallestreroAnna GarutiAlessio NencioniGabriele ZoppoliFranco PatronePeter BrossartIlaria RoccoAlessandra Piccini
- Cited by
- Cancer ResearchHematologyGenetics
- Partner nations
- ItalyUnited StatesGermany
In The Last Decade
Gabriella Cirmena
38 papers receiving 800 citations
Peers
Comparison fields: 5 of 87
- Cancer Research 229
- Hematology 108
- Genetics 83
- Oncology 188
- Molecular Biology 383
Countries citing papers authored by Gabriella Cirmena
This map shows the geographic impact of Gabriella Cirmena's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gabriella Cirmena with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gabriella Cirmena more than expected).
Fields of papers citing papers by Gabriella Cirmena
This network shows the impact of papers produced by Gabriella Cirmena. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gabriella Cirmena. The network helps show where Gabriella Cirmena may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Gabriella Cirmena, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2023 | 9 | |
| 3 | 2023 | 2 | |
| 4 | 2023 | 3 | |
| 5 | 2021 | 5 | |
| 6 | 2020 | 18 | |
| 7 | 2016 | 118 | |
| 8 | 2015 | 24 | |
| 9 | 2013 | 6 | |
| 10 | 2012 | 20 | |
| 11 | 2010 | 26 | |
| 12 | Molecular diagnosis and monitoring of chronic myelogenous leukemia: BCR-Abl and more. | 2010 | 1 |
| 13 | 2010 | 21 | |
| 14 | 2009 | 9 | |
| 15 | 2009 | 20 | |
| 16 | 2008 | 34 | |
| 17 | 2007 | 9 | |
| 18 | 2007 | 49 | |
| 19 | 2006 | 71 | |
| 20 | 2006 | 60 |
About Gabriella Cirmena
Gabriella Cirmena is a scholar working on Cancer Research, Hematology and Genetics, having authored 41 papers that have together received 813 indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (9 papers), Chronic Myeloid Leukemia Treatments (8 papers), Chronic Lymphocytic Leukemia Research (6 papers), Genetic factors in colorectal cancer (6 papers), HER2/EGFR in Cancer Research (5 papers), PARP inhibition in cancer therapy (4 papers), Alzheimer's disease research and treatments (4 papers) and Eosinophilic Disorders and Syndromes (4 papers). The work is most often cited by research in Cancer Research (229 citations), Hematology (108 citations) and Genetics (83 citations). Gabriella Cirmena has collaborated with scholars based in Italy, United States and Germany. Frequent co-authors include Alberto Ballestrero, Anna Garuti, Alessio Nencioni, Gabriele Zoppoli, Franco Patrone, Peter Brossart, Ilaria Rocco, Alessandra Piccini, David N. Brown and Roberta Borghi. Their work appears in journals such as Journal of Biological Chemistry, Blood and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.